Infusion-related angioedema associated with infliximab-abda: Case report.

CONCLUSION: A 37-year-old man developed infusion-related angioedema with use of infliximab-abda. Discontinuation of the biosimilar product along with supportive care brought about resolution of angioedema. There are no prior published reports of infusion-related angioedema reactions secondary to infliximab-abda use.
PMID: 33031494 [PubMed - as supplied by publisher]

Source: American Journal of Health-System Pharmacy : AJHP - October 8, 2020 Category: Drugs & Pharmacology Authors: Herndon K, Dewitt A, Gillion A, Pattanaik D Tags: Am J Health Syst Pharm Source Type: research